Golden Meditech Expects to Declare a Special Dividend Following the Completion of the Fortress Transaction
PR Newswire - Tue Apr 29, 6:15AM CDT
Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, announced today that it intends to declare a special dividend and issue bonus warrants to its qualifying shareholders following the completion of the sale of its interest in Fortress Group Limited ("Fortress"
Golden Meditech Sells 27.9% of Interest In Fortress Group Limited for US$101,264,437
PR Newswire - Tue Mar 25, 6:25AM CDT
Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China announced the sale of 2,942 ordinary shares, representing approximately 27.9% of the issued share capital of Fortress Group Limited ("Fortress"
Golden Meditech Announces 2013 / 2014 Interim Results
PR Newswire - Mon Nov 25, 5:39AM CST
* Excluding loss of HK$260,061,000 (6 months ended 30 September 2012: gain of HK$28,776,000) due to the fair value changes of financial assets and liabilities
Golden Meditech Proposes Open Offer to Eligible Shareholders to Subscribe One Offer Share for Every Two Shares Held
PR Newswire - Tue Nov 19, 8:51AM CST
Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China proposes a share issue to existing shareholders by way of an open offer on the basis of one offer share for every two shares held at the subscription price of HK$0.50 per offer share. Existing shareholders have the right to apply for excess shares that are not taken up and those shares will be allocated on pro rata basis of their shareholdings on the record date.
Golden Meditech Announces 2012 / 2013 Annual Results
PR Newswire - Fri Jun 28, 10:06AM CDT
Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March 2013 ("Fiscal Year"